HP INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
(Unaudited)
(In millions)
Nine months ended | |||||||
July 31, 2021 | July 31, 2020 | ||||||
Cash flows from operating activities: | |||||||
Net earnings | $ | 3,404 | $ | 2,176 | |||
Adjustments to reconcile net earnings to net cash provided by operating activities: | |||||||
Depreciation and amortization | 585 | 593 | |||||
Stock-based compensation expense | 260 | 221 | |||||
Restructuring and other charges | 216 | 431 | |||||
Deferred taxes on earnings | (93 | ) | 146 | ||||
Other, net | 254 | 281 | |||||
Changes in operating assets and liabilities, net of acquisitions: | |||||||
Accounts receivable | 503 | 699 | |||||
Inventory | (2,225 | ) | (247 | ) | |||
Accounts payable | 1,140 | (433 | ) | ||||
Net investment in leases | (78 | ) | (112 | ) | |||
Taxes on earnings | 19 | (238 | ) | ||||
Restructuring and other | (166 | ) | (412 | ) | |||
Other assets and liabilities | (258 | ) | (663 | ) | |||
Net cash provided by operating activities | 3,561 | 2,442 | |||||
Cash flows from investing activities: | |||||||
Investment in property, plant and equipment | (410 | ) | (464 | ) | |||
Proceeds from the sale of property, plant and equipment | — | 3 | |||||
Purchases of available-for-sale securities and other investments | (24 | ) | (533 | ) | |||
Maturities and sales of available-for-sale securities and other investments | 283 | 303 | |||||
Collateral posted for derivative instruments | 121 | (240 | ) | ||||
Payment made in connection with business acquisitions, net of cash acquired | (582 | ) | — | ||||
Net cash used in investing activities | (612 | ) | (931 | ) | |||
Cash flows from financing activities: | |||||||
Proceed from short-term borrowings with original maturities greater than 90 days | 22 | 19 | |||||
Proceeds from debt, net of issuance costs | 2,052 | 3,051 | |||||
Payment of debt | (1,192 | ) | (1,788 | ) | |||
Stock-based award activities and others | (42 | ) | (125 | ) | |||
Repurchase of common stock | (4,495 | ) | (1,767 | ) | |||
Cash dividends paid | (719 | ) | (759 | ) | |||
Net cash used in financing activities | (4,374 | ) | (1,369 | ) | |||
(Decrease) increase in cash and cash equivalent | (1,425 | ) | 142 | ||||
Cash and cash equivalents at beginning of period | 4,864 | 4,537 | |||||
Cash and cash equivalents at end of period | $ | 3,439 | $ | 4,679 |